We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Oxford–AstraZeneca Vaccine Not Associated With Overall Risk of Thromboembolic Events, Says EMA

News   Mar 19, 2021

 
Oxford–AstraZeneca Vaccine Not Associated With Overall Risk of Thromboembolic Events, Says EMA
 
 
Advertisement
 

RELATED ARTICLES

Study Finds COVID-19 Vaccines Do Not Damage the Placenta in Pregnancy

News

A new Northwestern Medicine study of placentas from patients who received the COVID-19 vaccine during pregnancy found no evidence of injury, adding to the growing literature that COVID-19 vaccines are safe in pregnancy.

READ MORE

Comprehensive Map of the SARS-CoV-2 Genome Published

News

Researchers have generated a complete gene annotation of the SARS-CoV-2 genome after performing an extensive comparative genomics study.

READ MORE

Which Antibodies Best Neutralize the Coronavirus In COVID-19 Patients?

News

Scientists have assessed various antigen-specific antibodies and have determined which of them had the strongest neutralizing activity against SARS-CoV-2.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE